Case Reports in Urology / 2019 / Article / Tab 1

Case Report

Stauffer’s Syndrome in Patient with Metastatic Prostate Cancer

Table 1

Laboratory findings during hospitalization.

AnalysisDay 1Day 7Day 14Reference range5 months prior to admission date

AST, U/L16151880-3332
Bilirubin, umol/L1651622995-2113
Direct-bilirubin, umol/L1321332370-54
Indirect-bilirubin, umol/L3329630-169
Testosterone, ng/dL12.7686.49-788.22
Alkaline phosphatase U/L2513141693446-1161356
Alkaline phosphatase bone fraction (ALP2), U/L3665.5-22.9
LDH, U/L350592120-246
GGT, U/L11745153610-72
CRP, mg/L24.6736.2267.760-53.6
IL-6, pg/mL57<3.4
PSA, ng/mL66.0191.780-3.99
APTT, sec.36.341.846.126-3639.5
Prothrombin index,%87.618.420.770-12074.5
Fibrinogen, g/L5.738.588.680-0.51.68

ALT- alanine aminotransferase; AST- aspartate transaminase; GGT- gamma-glutamyl transferase; CRP- C reactive protein; IL-6- interleukin 6; LDH- lactate dehydrogenase; PSA – prostate specific antigen; APTT – activated partial thromboplastin time; INR – international normalized ratio of prothrombin time of blood coagulation.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.